Z-0455-2022 Class II Terminated

Recalled by Qiagen Sciences LLC — Germantown, MD

FDA device recall Z-0455-2022 was initiated by Qiagen Sciences LLC on Nov 8, 2021 and is designated Class II. Reason for recall: The firm identified sixteen (16) faulty cartridges in LOT 210209, which contain incorrect primer-probe mixes in the reaction chambers. If an affected cartridge is used, false-negative, false-positive… The recall status is terminated (terminated Mar 29, 2023). Affected quantity: 376 kits.

Recall details

Product Type
Devices
Report Date
Jan 12, 2022
Initiation Date
Nov 8, 2021
Termination Date
Mar 29, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
376 kits

Product description

QIAstat-Dx Respiratory SARS-CoV-2 Panel (US IVD under FDA EUA 200075); REF 691223

Reason for recall

The firm identified sixteen (16) faulty cartridges in LOT 210209, which contain incorrect primer-probe mixes in the reaction chambers. If an affected cartridge is used, false-negative, false-positive, or both false-negative and false-positive results could occur.

Distribution pattern

Domestic distribution to AL, DC, KY, MD, ME, NJ, OK< PA, and TX. No foreign distribution.

Code information

LOT 210209 UDI (01)14053228038846(17)211127(10)210209(24)691223 Serial Numbers: 412092551 412092559 412092552 412092560 412092553 412092561 412092554 412092563 412092555 412092564 412092556 412092565 412092557 412092566 412092558 412092567

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0455-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0455-2022. Report a data issue: hello@regdatalab.com.